1 – 10 of 31
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Effect of therapy switch on time to second-line antiretroviral treatment failure in HIV-infected patients
(
- Contribution to journal › Article
- 2016
-
Mark
Viral blips during suppressive antiretroviral treatment are associated with high baseline HIV-1 RNA levels
(
- Contribution to journal › Article
-
Mark
Infection-related and -unrelated malignancies, HIV and the aging population
(
- Contribution to journal › Article
- 2015
-
Mark
Six-week follow-up after HIV-1 exposure: a position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy.
(
- Contribution to journal › Article
- 2014
-
Mark
Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish recommendations 2013
(
- Contribution to journal › Scientific review
-
Mark
Risk of HIV transmission from patients on antiretroviral therapy: A position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy
(
- Contribution to journal › Scientific review
- 2013
-
Mark
Lopinavir/ritonavir, atazanavir/ritonavir, and efavirenz in antiretroviral-naive HIV-1-infected individuals over 144 weeks: An open-label randomized controlled trial
(
- Contribution to journal › Article
- 2012
-
Mark
Prevalence of sexually transmitted infections among women attending antenatal clinics in Tanga, north eastern Tanzania
(
- Contribution to journal › Article
- 2011
-
Mark
Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish Recommendations 2010
(
- Contribution to journal › Scientific review
-
Mark
Bilirubin-A Potential Marker of Drug Exposure in Atazanavir-Based Antiretroviral Therapy
(
- Contribution to journal › Article